The price of this share is at 4,15$, Sutro Biopharma is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Arturo Molina (Chief Medical Officer), Craig Berman (Vice President-Clinical Development), Edward C. Albini (Chief Financial Officer & Secretary), Henry Heinsohn (Vice President-Technology & Innovation), Nicki Vasquez (Senior VP-Operations & Alliance Management), Nicole M. Chieffo (Vice President-Clinical Operations), Shabbir T. Anik (Chief Technical Operations Officer), Trevor Hallam (Chief Scientific Officer & President-Research), Werner Rubas (Vice President-Preclinical Development), William J. Newell (President, Chief Executive Officer & Director) and its address is 310 UTAH AVENUE SUITE 150, SOUTH SAN FRANCISCO, California, 94080, United States.

The closing price of the stock yesterday was desconocido$.

The current range on the same day is from 3,93$ - 4,17$, with a percentage difference of 4,05$ quite wide that helps to be able to do day trading.

He earns an annual income of desconocido.

The last value we have registered for the opening is desconocido.

If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.

The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.